The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:

1		Dec. 31, 20Y3	Dec. 31, 20Y2
2	Assets
3	Cash	$155,000.00	$150,000.00
4	Accounts receivable (net)	450,000.00	400,000.00
5	Inventories	770,000.00	750,000.00
6	Investments	0.00	100,000.00
7	Land	500,000.00	0.00
8	Equipment	1,400,000.00	1,200,000.00
9	Accumulated depreciation-equipment	(600,000.00)	(500,000.00)
10	Total assets	$2,675,000.00	$2,100,000.00
11	Liabilities and Stockholders Equity
12	Accounts payable (merchandise creditors)	$340,000.00	$300,000.00
13	Accrued expenses payable (operating expenses)	45,000.00	50,000.00
14	Dividends payable	30,000.00	25,000.00
15	Common stock, $4 par	700,000.00	600,000.00
16	Paid-in capital in excess of parcommon stock	200,000.00	175,000.00
17	Retained earnings	1,360,000.00	950,000.00
18	Total liabilities and stockholders equity	$2,675,000.00	$2,100,000.00

The income statement for the year ended December 31, 20Y3, is as follows:

1	Sales		$3,000,000.00
2	Cost of goods sold		(1,400,000.00)
3	Gross profit		$1,600,000.00
4	Operating expenses:
5	Depreciation expense	$100,000.00
6	Other operating expenses	950,000.00
7	Total operating expenses		(1,050,000.00)
8	Operating income		$550,000.00
9	Other revenue:
10	Gain on sale of investments		75,000.00
11	Income before income tax		$625,000.00
12	Income tax expense		(125,000.00)
13	Net income		$500,000.00

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

	a. The investments were sold for $175,000 cash.
	b. Equipment and land were acquired for cash.
	c. There were no disposals of equipment during the year.
	d. The common stock was issued for cash.
	e. There was a $90,000 debit to Retained Earnings for cash dividends declared.

Required:

Prepare a statement of cash flows, using the direct method of presenting cash flows from (used for) operating activities.

Labels
Cash flows from (used for) operating activities
Cash flows from (used for) investing activities
Cash flows from (used for) financing activities
For the Year Ended December 31, 20Y3
December 31, 20Y3
Amount Descriptions
Cash paid for dividends
Cash paid for purchase of equipment
Cash paid for purchase of land
Cash paid for purchase of treasury stock
Cash payments for income taxes
Cash payments for inventories
Cash payments for operating expenses
Cash received from customers
Cash received from sale of common stock
Cash received from sale of investments
Cash balance, January 1, 20Y3
Cash balance, December 31, 20Y3
Depreciation
Gain on sale of investments
Issuance of common stock for acquisition of land
Issuance of common stock for purchase of equipment
Loss on sale of investments
Net cash flows from financing activities
Net cash flows from investing activities
Net cash flows from operating activities
Net cash flows used for financing activities
Net cash flows used for investing activities
Net cash flows used for operating activities
Net decrease in cash
Net increase in cash

Prepare a statement of cash flows, using the direct method of presenting cash flows from (used for) operating activities.

Statement of Cash Flows Instructions

Livers Inc.

Statement of Cash Flows

(Label)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20